<DOC>
	<DOC>NCT01262157</DOC>
	<brief_summary>Low intensity shock waves (LISW) have been proven in animal studies to induce local growth of new blood vessels. The investigators hypothesized that LISW therapy could improve the symptoms of patients with erectile dysfunction resulting from a problem of blood supply that do not respond to oral therapy (PDE-5 inhibitors).</brief_summary>
	<brief_title>Low Intensity ShockWave Therapy for ED in Non Responders to PDE5i - a Double Blind Placebo Controlled Study</brief_title>
	<detailed_description>In this study Low intensity shockwaves (1/10 the ones used in Lithotripsy) are delivered directly to the penile tissue using a specially designed shockwave device and probe. Shock wave therapy is applied twice a week for three weeks , then a 3- week interval with no therapy followed by another 3 week period of twice a week shock wave therapy. Before and after sexual function questionnaires and objective measures of erectile function will be performed.</detailed_description>
	<mesh_term>Erectile Dysfunction</mesh_term>
	<criteria>ED of more than 6 months Rigidity score &lt; 3 during PDE5i therapy SHIM &lt;21 during PDE5i therapy Non hormonal, neurological or psychological pathology Stable heterosexual relationship for more than 3 months Prior prostatectomy surgery Any unstable medical, psychiatric, spinal cord injury and penile anatomical abnormalities Clinically significant chronic hematological disease Antiandrogens, oral or injectable androgens Radiotherapy in pelvic region</criteria>
	<gender>Male</gender>
	<minimum_age>20 Years</minimum_age>
	<maximum_age>85 Years</maximum_age>
	<verification_date>May 2010</verification_date>
	<keyword>Erectile dysfunction</keyword>
	<keyword>PDE5 Inhibitor</keyword>
	<keyword>Low intensity shock wave therapy.</keyword>
</DOC>